Opus Genetics, Inc.
IRD· Nasdaq
IRDOpus Genetics, Inc.
Filed Mar 7, 2019 · 10-K · 66 days after period end · 0001140361-19-004539
| Metric | Q4 2018 | Q4 2017 | Q4 2016 | Q4 2015 |
|---|---|---|---|---|
| Net Income | -$3.12M | -$3.59M | -$525.48K | -$2.85M |
| EPS Diluted | -$0.09 | -$0.12 | -$0.02 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Opus Genetics, Inc. · CIK 1228627 · Engraved from SEC EDGAR
ended Dec 31, 2018 · filed Mar 7, 2019 · 66 d after period end
